Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
- Conditions
- EnterocolitisAntibiotic-Associated ColitisPseudomembranous Colitis
- Registration Number
- NCT00304876
- Lead Sponsor
- Michael E. DeBakey VA Medical Center
- Brief Summary
The investigators propose to study intensively the bacteriology of feces in C. difficile associated diarrheal disease, using a variety of conventional and very up-to-date techniques.
- Detailed Description
Clostridium difficile associated colitis is an increasing problem in hospitals throughout the developed world; the number of cases has increased, and the failure to respond to conventional therapy has become far more common. The investigators have recently documented in the medical literature (Clin Infect Dis, June, 2005; Lancet Infect Dis, August, 2005). Possible reasons for failure of treatment include persistence of C. difficile and/or imbalance of other bacterial flora in the colon. The bacteriology of fecal flora in C. difficile associated diarrhea has not been studied.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5
- Patients with antibiotic-associated diarrhea with a positive assay for C. difficile toxin
- Patients with antibiotic-associated diarrhea with 3 negative assays for C. difficile toxin
- Patients with antibiotic-associated diarrhea that has failed to respond to conventional therapy
- Hospitalized patients who have received >2 antibiotics and who have no symptoms of diarrhea or abdominal discomfort
- none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Johns Hopkins Medical Research Institute
🇺🇸Baltimore, Maryland, United States
Michael E. DeBakey Veterans Affairs Medical Center
🇺🇸Houston, Texas, United States